Ankylosing spondylitis Market Analysis

Ankylosing spondylitis (AS), also called Bechterew's disease is a form of arthritis that primarily affects the spine, although other joints may also be involved. It causes inflammation of the spinal joints (vertebrae) that can lead to severe, chronic pain and discomfort. It is a type of axial spondyloarthritis (axSpA) that refers to a particular form of spondyloarthritis in which the predominant symptom is inflammatory back pain.

Ankylosing spondylitis Market Key Facts
Ankylosing spondylitis is considered to be more prevalent in men as compared to women.
There were 1,389,116 prevalent cases of Ankylosing Spondylitis in 2017 in 7MM. These prevalent cases are further expected to increase for the study period 2017–2030.
Among the European countries, Germany had the highest prevalent population of Ankylosing Spondylitis with ~374,705 cases, followed by Italy with around 192,013 cases in 2017. Spain had the lowest prevalent pool of Ankylosing Spondylitis in 2017.
Japan had the lowest prevalent population of Ankylosing Spondylitis in 2017 with 7,540 cases in 2017.
AS is found to be more prevalent in men as compared to women, with around 358,880 male and 146,585 female cases in 2017 in the United States. Further in case of severity, majority of cases belong to stable AS (mild), as compared to active AS (moderate to severe)

For more details visit:
https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhterevs-disease-market